A citation-based method for searching scientific literature

Fen Zhuge, Yinhua Ni, Mayumi Nagashimada, Naoto Nagata, Liang Xu, Naofumi Mukaida, Shuichi Kaneko, Tsuguhito Ota. Diabetes 2016
Times Cited: 103







List of co-cited articles
747 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Obesity induces a phenotypic switch in adipose tissue macrophage polarization.
Carey N Lumeng, Jennifer L Bodzin, Alan R Saltiel. J Clin Invest 2007
17

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals.
David Patsouris, Ping-Ping Li, Divya Thapar, Justin Chapman, Jerrold M Olefsky, Jaap G Neels. Cell Metab 2008
571
12

Obesity is associated with macrophage accumulation in adipose tissue.
Stuart P Weisberg, Daniel McCann, Manisha Desai, Michael Rosenbaum, Rudolph L Leibel, Anthony W Ferrante. J Clin Invest 2003
12

Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.
Daniela Lamers, Susanne Famulla, Nina Wronkowitz, Sonja Hartwig, Stefan Lehr, D Margriet Ouwens, Kristin Eckardt, Jean M Kaufman, Mikael Ryden, Stefan Müller,[...]. Diabetes 2011
384
12

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
11

CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status.
Hironori Kitade, Kazuki Sawamoto, Mayumi Nagashimada, Hiroshi Inoue, Yasuhiko Yamamoto, Yoshimichi Sai, Toshinari Takamura, Hiroshi Yamamoto, Ken-ichi Miyamoto, Henry N Ginsberg,[...]. Diabetes 2012
180
11


Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.
Zubair Shah, Thomas Kampfrath, Jeffrey A Deiuliis, Jixin Zhong, Colleen Pineda, Zhekang Ying, Xiaohua Xu, Bo Lu, Susan Moffatt-Bruce, Rekha Durairaj,[...]. Circulation 2011
269
11

Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
Devram S Ghorpade, Lale Ozcan, Ze Zheng, Sarah M Nicoloro, Yuefei Shen, Emily Chen, Matthias Blüher, Michael P Czech, Ira Tabas. Nature 2018
117
10

Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
Keizo Kanasaki, Sen Shi, Megumi Kanasaki, Jianhua He, Takako Nagai, Yuka Nakamura, Yasuhito Ishigaki, Munehiro Kitada, Swayam Prakash Srivastava, Daisuke Koya. Diabetes 2014
224
9

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
Haiyan Xu, Glenn T Barnes, Qing Yang, Guo Tan, Daseng Yang, Chieh J Chou, Jason Sole, Andrew Nichols, Jeffrey S Ross, Louis A Tartaglia,[...]. J Clin Invest 2003
9

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
9

Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
Yinhua Ni, Mayumi Nagashimada, Lili Zhan, Naoto Nagata, Masuko Kobori, Minoru Sugiura, Kazunori Ogawa, Shuichi Kaneko, Tsuguhito Ota. Endocrinology 2015
55
14

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
Noriko Satoh-Asahara, Yousuke Sasaki, Hiromichi Wada, Mayu Tochiya, Azusa Iguchi, Reiko Nakagawachi, Shinji Odori, Shigeo Kono, Koji Hasegawa, Akira Shimatsu. Metabolism 2013
130
8

A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
Jixin Zhong, Xiaoquan Rao, Jeffrey Deiuliis, Zachary Braunstein, Vimal Narula, Jeffrey Hazey, Dean Mikami, Bradley Needleman, Abhay R Satoskar, Sanjay Rajagopalan. Diabetes 2013
115
8


Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
Satoru Takashima, Hiroki Fujita, Hiromi Fujishima, Tatsunori Shimizu, Takehiro Sato, Tsukasa Morii, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2016
62
11

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.
Justin I Odegaard, Roberto R Ricardo-Gonzalez, Matthew H Goforth, Christine R Morel, Vidya Subramanian, Lata Mukundan, Alex Red Eagle, Divya Vats, Frank Brombacher, Anthony W Ferrante,[...]. Nature 2007
7

Macrophage plasticity and polarization: in vivo veritas.
Antonio Sica, Alberto Mantovani. J Clin Invest 2012
7

Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate.
Dong-Sung Lee, Eun-Sol Lee, Md Morshedul Alam, Jun-Hyeog Jang, Ho-Sub Lee, Hyuncheol Oh, Youn-Chul Kim, Zahid Manzoor, Young-Sang Koh, Dae-Gil Kang,[...]. Metabolism 2016
32
21

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
Hajime Kanda, Sanshiro Tateya, Yoshikazu Tamori, Ko Kotani, Ken-ichi Hiasa, Riko Kitazawa, Sohei Kitazawa, Hitoshi Miyachi, Sakan Maeda, Kensuke Egashira,[...]. J Clin Invest 2006
7

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease.
Christian Baumeier, Luisa Schlüter, Sophie Saussenthaler, Thomas Laeger, Maria Rödiger, Stella Amelie Alaze, Louise Fritsche, Hans-Ulrich Häring, Norbert Stefan, Andreas Fritsche,[...]. Mol Metab 2017
59
11

Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.
Masayuki Miyazaki, Masaki Kato, Kosuke Tanaka, Masatake Tanaka, Motoyuki Kohjima, Kazuhiko Nakamura, Munechika Enjoji, Makoto Nakamuta, Kazuhiro Kotoh, Ryoichi Takayanagi. Mol Med Rep 2012
98
7

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
7

Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, Kosuke Azuma, Rica Tanaka, Satoshi Fujimura, Dewi Sukmawati, Takashi Nomiyama, Akio Kanazawa, Ryuzo Kawamori,[...]. Endocrinology 2013
125
7

Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice.
Wenbin Zheng, Jing Zhou, Shasha Song, Wen Kong, Wenfang Xia, Lulu Chen, Tianshu Zeng. Int J Endocrinol 2018
24
29

Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.
Elodie M Varin, Erin E Mulvihill, Jacqueline L Beaudry, Gemma Pujadas, Shai Fuchs, Jean-François Tanti, Sofia Fazio, Kirandeep Kaur, Xiemin Cao, Laurie L Baggio,[...]. Cell Metab 2019
57
12

Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
Sen Shi, Swayam Prakash Srivastava, Megumi Kanasaki, Jianhua He, Munehiro Kitada, Takako Nagai, Kyoko Nitta, Susumu Takagi, Keizo Kanasaki, Daisuke Koya. Kidney Int 2015
96
6

The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Oleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder, Karoline von Websky, Viktoriia Antonenko, Yuliya Sharkovska, Lyubov Chaykovska, Jan Rahnenführer, Ahmed A Hasan, Harald Tammen,[...]. Kidney Int 2016
51
11

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.
Ravi Nistala, Javad Habibi, Annayya Aroor, James R Sowers, Melvin R Hayden, Alex Meuth, William Knight, Tamara Hancock, Thomas Klein, Vincent G DeMarco,[...]. Obesity (Silver Spring) 2014
55
10

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
6

Inflammation and metabolic disorders.
Gökhan S Hotamisligil. Nature 2006
6

Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.
Swenja Kröller-Schön, Maike Knorr, Michael Hausding, Matthias Oelze, Alexandra Schuff, Richard Schell, Stephan Sudowe, Alexander Scholz, Steffen Daub, Susanne Karbach,[...]. Cardiovasc Res 2012
130
6

M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.
Jinghong Wan, Merieme Benkdane, Fatima Teixeira-Clerc, Stéphanie Bonnafous, Alexandre Louvet, Fouad Lafdil, Françoise Pecker, Albert Tran, Philippe Gual, Ariane Mallat,[...]. Hepatology 2014
296
6

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.
Satoshi Nishimura, Ichiro Manabe, Mika Nagasaki, Koji Eto, Hiroshi Yamashita, Mitsuru Ohsugi, Makoto Otsu, Kazuo Hara, Kohjiro Ueki, Seiryo Sugiura,[...]. Nat Med 2009
6

Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E.
Yinhua Ni, Mayumi Nagashimada, Fen Zhuge, Lili Zhan, Naoto Nagata, Akemi Tsutsui, Yasuni Nakanuma, Shuichi Kaneko, Tsuguhito Ota. Sci Rep 2015
122
6

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.
Justin I Odegaard, Roberto R Ricardo-Gonzalez, Alex Red Eagle, Divya Vats, Christine R Morel, Matthew H Goforth, Vidya Subramanian, Lata Mukundan, Anthony W Ferrante, Ajay Chawla. Cell Metab 2008
595
6

Increased oxidative stress in obesity and its impact on metabolic syndrome.
Shigetada Furukawa, Takuya Fujita, Michio Shimabukuro, Masanori Iwaki, Yukio Yamada, Yoshimitsu Nakajima, Osamu Nakayama, Makoto Makishima, Morihiro Matsuda, Iichiro Shimomura. J Clin Invest 2004
6

DPP4 in Diabetes.
Diana Röhrborn, Nina Wronkowitz, Juergen Eckel. Front Immunol 2015
188
6

Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.
Jun Shirakawa, Hideki Fujii, Kei Ohnuma, Koichiro Sato, Yuzuru Ito, Mitsuyo Kaji, Eri Sakamoto, Megumi Koganei, Hajime Sasaki, Yoji Nagashima,[...]. Diabetes 2011
185
6

Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro.
Henrike Sell, Matthias Blüher, Nora Klöting, Raphaela Schlich, Miriam Willems, Florian Ruppe, Wolfram Trudo Knoefel, Arne Dietrich, Barbara A Fielding, Peter Arner,[...]. Diabetes Care 2013
136
6

Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
174
6

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck, Gordon S Howarth, Catherine A Abbott. Trends Pharmacol Sci 2009
182
6

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance.
Wan Huang, Anantha Metlakunta, Nikolaos Dedousis, Pili Zhang, Ian Sipula, John J Dube, Donald K Scott, Robert M O'Doherty. Diabetes 2010
323
6

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
Michael A Nauck, Juris J Meier, Matthew A Cavender, Mirna Abd El Aziz, Daniel J Drucker. Circulation 2017
233
6

DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.
Jixin Zhong, Andrei Maiseyeu, Stephen N Davis, Sanjay Rajagopalan. Circ Res 2015
120
6


Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.
Annayya R Aroor, Javad Habibi, David A Ford, Ravi Nistala, Guido Lastra, Camila Manrique, Merlow M Dunham, Kaitlin D Ford, John P Thyfault, Elizabeth J Parks,[...]. Diabetes 2015
53
11

DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation.
Takanori Shinjo, Yusuke Nakatsu, Misaki Iwashita, Tomomi Sano, Hideyuki Sakoda, Hisamitsu Ishihara, Akifumi Kushiyama, Midori Fujishiro, Toshiaki Fukushima, Yoshihiro Tsuchiya,[...]. Am J Physiol Endocrinol Metab 2015
41
14

A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Junichi Matsubara, Seigo Sugiyama, Koichi Sugamura, Taishi Nakamura, Yukio Fujiwara, Eiichi Akiyama, Hirofumi Kurokawa, Toshimitsu Nozaki, Keisuke Ohba, Masaaki Konishi,[...]. J Am Coll Cardiol 2012
209
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.